Status:
COMPLETED
Biological Markers Predicting Exercise Capacity in CF-LVAD Patients.
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Heart Failure
Eligibility:
All Genders
18-90 years
Brief Summary
Establishing the association between biological markers and exercise capacity in continuous-flow left ventricular assist device patients.
Detailed Description
The aim of this study is to investigate if specific biological markers can predict exercise capacity in advanced heart failure patients supported with continuous-flow left ventricular assist device pa...
Eligibility Criteria
Inclusion
- Stable CF-LVAD patients.
Exclusion
- Unstable CF-LVAD patients.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 24 2016
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT02303236
Start Date
November 1 2014
End Date
December 24 2016
Last Update
October 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Rigshospitalet.
Copenhagen, Kbh Oe, Denmark, 2100